Pharmacodynamics and tolerance of two nadroparin formulations (10250 and 20500 anti-Xa IU/ml-1) delivered for 10 days at therapeutic dose - Boneu,B.; Navarro,C.; Cambus,J.P. (Thromb Haemost, 1998)